Slashdot: FDA Designates MDMA As ‘Breakthrough Therapy’ For PTSD
FDA Designates MDMA As ‘Breakthrough Therapy’ For PTSD Published on August 29, 2017 at 12:00PM In what could lead to a faster path to pharmaceutical approval, the U.S. Food and Drug Administration (FDA) has designated methylenedioxymethamphetamine (MDMA) as a “breakthrough therapy” in the treatment of post-traumatic stress disorder (PTSD). Futurism reports: The Multidisciplinary Association for…